Heatwave Health Impact: RIVM reports at least 911 excess deaths in the Netherlands between June 22 and July 5, with the biggest rise among people aged 80+ and in southern and eastern regions; officials warn heat and air pollution likely played a role. End-of-Life Law Watch (Europe): France’s National Assembly has given final approval to a right to assisted dying under strict safeguards for adults with serious, incurable, life-threatening illness and unbearable suffering, with eligibility checks, a reflection period, and the option to withdraw. Dutch Digital Security: Seven Dutch provinces will jointly set up a digital security center with a shared Security Operations Center to meet new EU incident-reporting rules, each contributing up to €500,000 annually. Dutch Elm Disease Update: Regina confirms Dutch Elm Disease is tracking at about the same level as last year, with ongoing monitoring and tree removal plans to limit spread. Clinical Development (Women’s Health): Amsterdam-based Arletta Pharma says the FDA endorsed key elements of its Phase 2 MONARCH dose-ranging study and is open to a streamlined path toward a single pivotal Phase 3 for Lybrido™ in the US. Healthcare Sector Finance: argenx will hold a conference call on July 23 to discuss its half-year 2026 results and Q2 update.